New Perspectives in Nuclear Neurology for the Evaluation of Parkinson's Disease

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author BENADIBA, Marcel FMUSP-HC
LUURTSEMA, Gert
TUMAS, Vitor
BUCHPIGEL, Carlos Alberto FMUSP-HC
BUSATTO, Geraldo F. FMUSP-HC
dc.date.issued 2013
dc.identifier.citation JOURNAL OF PARKINSONS DISEASE, v.3, n.3, p.301-323, 2013
dc.identifier.issn 1877-7171
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/4021
dc.description.abstract The pathophysiology of Parkinson's disease (PD) has not yet been completely elucidated. However, during the past few years, significant progress has been made in understanding the intra- and extracellular mechanisms by which proteins such as alpha-synuclein and neuroinflammatory molecules may display impaired function and/or expression in PD. Recent developments in imaging techniques based on positron emission tomography (PET) and single photon emission computed tomography (SPECT) now allow the non-invasive tracking of such molecular targets of known relevance to PD in vivo. This article summarizes recent PET and SPECT studies of new radiopharmaceuticals and discusses their potential role and perspectives for use in the fields of new drug development and early diagnosis for PD, as well to aid in differential diagnosis and monitoring of the progression of PD.
dc.description.sponsorship · Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Brazilian agency
dc.language.iso eng
dc.publisher IOS PRESS
dc.relation.ispartof Journal of Parkinsons Disease
dc.rights restrictedAccess
dc.subject single-photon emission-computed tomography; Parkinson disease; radioactive tracers; lipid metabolism
dc.subject.other positron-emission-tomography; blood-brain-barrier; p-glycoprotein function; tumor-necrosis-factor; in-vivo evaluation; cancer resistance protein; acid amide hydrolase; interleukin-1 receptor antagonist; cannabinoid cb1 receptors; growth-factor-beta
dc.title New Perspectives in Nuclear Neurology for the Evaluation of Parkinson's Disease
dc.type article
dc.rights.holder Copyright IOS PRESS
dc.description.group LIM/21
dc.description.group LIM/43
dc.identifier.doi 10.3233/JPD-130207
dc.identifier.pmid 23981822
dc.type.category original article
dc.type.version publishedVersion
hcfmusp.author BENADIBA, Marcel:HC:LIM/21
hcfmusp.author BUCHPIGEL, Carlos Alberto:FM:MDR
hcfmusp.author BUSATTO, Geraldo F.:FM:MPS
hcfmusp.author.external · LUURTSEMA, Gert:Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, NL-9713 GZ Groningen, Netherlands
· TUMAS, Vitor:Univ Sao Paulo, NAPNA, Sao Paulo, Brazil; Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurociencias & Ciencias Comportamento, Ribeirao Preto, SP, Brazil
hcfmusp.origem.id 2-s2.0-84888859202
hcfmusp.origem.id WOS:000324405000007
hcfmusp.publisher.city AMSTERDAM
hcfmusp.publisher.country NETHERLANDS
hcfmusp.relation.reference · Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x
· Aboagye EO, 2010, BRIT J RADIOL, V83, P814, DOI 10.1259/bjr/77317821
· Agarwal S, 2012, MOL PHARMACEUT, V9, P678, DOI 10.1021/mp200465c
· Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664
· Amiry-Moghaddam M, 2005, FASEB J, V19, P1459, DOI 10.1096/fj.04-3515com
· Anderson CJ, 2009, CANCER BIOTHER RADIO, V24, P379, DOI 10.1089/cbr.2009.0674
· Annovazzi A, 2006, EUR J NUCL MED MOL I, V33, P474, DOI 10.1007/s00259-005-0001-6
· Aoyama S, 2000, J NEUROSCI, V20, P5848
· Arlicot N, 2008, EUR J NUCL MED MOL I, V35, P2203, DOI 10.1007/s00259-008-0834-x
· Arlicot N, 2011, NUCL MED BIOL, V39, P570
· Arlicot N, 2010, EUR J NUCL MED MOL I, V37, P2371, DOI 10.1007/s00259-010-1598-7
· Armentero MT, 2006, NEUROBIOL DIS, V22, P1, DOI 10.1016/j.nbd.2005.09.010
· Asari S, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-35
· Badaut Jerome, 2002, Journal of Cerebral Blood Flow and Metabolism, V22, P367
· Badaut J, 2010, NEUROSCIENCE, V168, P1047, DOI 10.1016/j.neuroscience.2009.10.030
· BAKHEIT AMO, 1995, POSTGRAD MED J, V71, P151
· Barbosa MT, 2006, MOVEMENT DISORD, V21, P800, DOI 10.1002/mds.20806
· Barksby HE, 2007, CLIN EXP IMMUNOL, V149, P217, DOI 10.1111/j.1365-2249.2007.03441.x
· Bartels AL, 2010, PARKINSONISM RELAT D, V16, P57, DOI 10.1016/j.parkreldis.2009.05.005
· Bartels AL, 2008, PARKINSONISM RELAT D, V14, P505, DOI 10.1016/j.parkreldis.2007.11.007
· Bartels AL, 2008, J NEURAL TRANSM, V115, P1001, DOI 10.1007/s00702-008-0030-y
· Bartels AL, 2011, CURR PHARM DESIGN, V17, P2771
· Bartels AL, 2009, NEUROBIOL AGING, V30, P1818, DOI 10.1016/j.neurobiolaging.2008.02.002
· Battista N, 2007, NEUROBIOL DIS, V27, P108, DOI 10.1016/j.nbd.2007.04.012
· Bauer A, 2003, NEUROIMAGE, V19, P1760, DOI 10.1016/S1053-8119(03)00241-6
· Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635
· Benadiba M, 2012, REV BRAS PSIQUIATR, V34, pS125, DOI 10.1016/j.rbp.2012.07.002
· Benito C, 2003, J NEUROSCI, V23, P11136
· Biegon A, 2010, SYNAPSE, V64, P801, DOI 10.1002/syn.20791
· Black YD, 2010, NEUROSCI LETT, V486, P161, DOI 10.1016/j.neulet.2010.09.043
· Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038
· Booij J, 1999, EUR J NUCL MED, V26, P171, DOI 10.1007/s002590050374
· Borghammer P, 2012, J NEUROL SCI, V313, P123, DOI 10.1016/j.jns.2011.09.010
· Brenn A, 2011, INT J ALZHEIMERS DIS, V2011
· Brooks DJ, 1997, BAILLIERE CLIN NEUR, V6, P69
· Bruggemann N, 2010, ARCH NEUROL-CHICAGO, V67, P1357, DOI 10.1001/archneurol.2010.281
· Bruno V, 1998, J NEUROSCI, V18, P9594
· Cao Q, 2007, EUR J NUCL MED MOL I, V34, P1832, DOI 10.1007/s00259-007-0451-0
· Cao W, 2007, NUCL MED COMMUN, V28, P895
· Castagnet PI, 2005, J NEUROCHEM, V94, P839, DOI 10.1111/j.1471-4159.2005.032747.x
· Casteels C, 2012, EUR J NUCL MED MOL I, V39, P1467, DOI 10.1007/s00259-012-2163-3
· Cawthorne C, 2011, BRIT J PHARMACOL, V162, P659, DOI 10.1111/j.1476-5381.2010.01068.x
· Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004
· Ching Alex Sik Chung, 2012, Insights Imaging, V3, P111, DOI 10.1007/s13244-011-0128-x
· Chu WM, 2013, CANCER LETT, V328, P222, DOI 10.1016/j.canlet.2012.10.014
· Chung SJ, 2011, MOVEMENT DISORD, V26, P1234, DOI 10.1002/mds.23604
· Colabufo NA, 2010, J MED CHEM, V53, P1883, DOI 10.1021/jm900743c
· Collins MA, 2013, NEUROTOX RES, V23, P105, DOI 10.1007/s12640-012-9360-5
· Dalfo E, 2005, J NEUROPATH EXP NEUR, V64, P816
· deWolde H, 1997, J NUCL MED, V38, P1369
· DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x
· Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495
· Do TM, 2012, J ALZHEIMERS DIS, V30, P155, DOI 10.3233/JAD-2012-112189
· Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219
· Dohgu S, 2004, CELL MOL NEUROBIOL, V24, P491, DOI 10.1023/B:CEMN.0000022776.47302.ce
· Doorduin J, 2009, MOL IMAGING BIOL, V11, P386, DOI 10.1007/s11307-009-0211-6
· Dorner B, 2011, BIOORGAN MED CHEM, V19, P2190, DOI 10.1016/j.bmc.2011.02.039
· Drukarch B, 2001, EXPERT OPIN INV DRUG, V10, P1855, DOI 10.1517/13543784.10.10.1855
· ElAli A, 2011, NEUROSCIENTIST, V17, P423, DOI 10.1177/1073858410391270
· ELLIOTT PNC, 1977, NEUROPHARMACOLOGY, V16, P333, DOI 10.1016/0028-3908(77)90070-3
· Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005
· Elstner M, 2011, ACTA NEUROPATHOL, V122, P75, DOI 10.1007/s00401-011-0828-9
· Emsley HCA, 2005, J NEUROL NEUROSUR PS, V76, P1366, DOI 10.1136/jnnp.2004.054882
· Esposito G, 2008, J NUCL MED, V49, P1414, DOI 10.2967/jnumed.107.049619
· Evens N, 2011, BIOORGAN MED CHEM, V19, P4499, DOI 10.1016/j.bmc.2011.06.033
· Fabelo N, 2011, MOL MED, V17, P1107, DOI 10.2119/molmed.2011.00119
· Farkas S, 2012, BRAIN RES BULL, V87, P504, DOI 10.1016/j.brainresbull.2012.02.012
· Feldmann M, 1998, SPRINGER SEMIN IMMUN, V20, P211, DOI 10.1007/BF00832008
· Ferrari CC, 2006, NEUROBIOL DIS, V24, P183, DOI 10.1016/j.nbd.2006.06.013
· Ferre S, 1997, TRENDS NEUROSCI, V20, P482, DOI 10.1016/S0166-2236(97)01096-5
· Ferrer I, 2011, J NEURAL TRANSM, V118, P821, DOI 10.1007/s00702-010-0482-8
· Ferrer I, 2009, J BIOENERG BIOMEMBR, V41, P425, DOI 10.1007/s10863-009-9243-5
· Ferrer I, 2012, NEUROBIOL DIS, V46, P508, DOI 10.1016/j.nbd.2011.10.019
· Ferrer I., 2011, PARKINSONS DIS, V2011, DOI 10.4061/2011/708404
· Foglio E, 2010, CURR NEUROPHARMACOL, V8, P112, DOI 10.2174/157015910791233150
· Fortt R, 2012, NUCL MED BIOL, V39, P1000, DOI 10.1016/j.nucmedbio.2012.03.004
· Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391
· Fredduzzi S, 2002, J NEUROSCI, V22, P1054
· Freeman BD, 2001, EXPERT OPIN BIOL TH, V1, P301, DOI 10.1517/14712598.1.2.301
· Freemantle E, 2009, J NUTR HEALTH AGING, V13, P293, DOI 10.1007/s12603-009-0026-9
· Frey KA, 2001, ADV NEUROL, V86, P237
· Fukumitsu N, 2003, ANN NUCL MED, V17, P511
· Fukumoto D, 2012, SYNAPSE, V66, P909, DOI 10.1002/syn.21584
· Gallagher CL, 2011, MOVEMENT DISORD, V26, P2032, DOI 10.1002/mds.23778
· Gao MZ, 2010, APPL RADIAT ISOTOPES, V68, P1950, DOI 10.1016/j.apradiso.2010.04.030
· Garcia-Segura LM, 2008, J NEUROENDOCRINOL, V20, P705, DOI 10.1111/j.1365-2826.2008.01713.x
· Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002
· Gerhard A, 2006, MOVEMENT DISORD, V21, P89, DOI 10.1002/mds.20668
· Godoy MCP, 2008, BRAIN, V131, P1880, DOI 10.1093/brain/awn101
· Golovko MY, 2009, MOL CELL BIOCHEM, V326, P55, DOI 10.1007/s11010-008-0008-y
· Gomes CV, 2011, BBA-BIOMEMBRANES, V1808, P1380, DOI 10.1016/j.bbamem.2010.12.001
· Gomez C, 2007, FRONT BIOSCI, V12, P1079, DOI 10.2741/2128
· Gonzalez-Cuyar LF, 2011, CURR NEUROL NEUROSCI, V11, P455, DOI 10.1007/s11910-011-0212-0
· Gordon R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-82
· Gowran A, 2011, CNS NEUROSCI THER, V17, P637, DOI 10.1111/j.1755-5949.2010.00195.x
· Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940
· Hao CS, 2010, TOXICOL LETT, V198, P225, DOI 10.1016/j.toxlet.2010.06.023
· Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597
· Hauser RA, 2005, DRUG AGING, V22, P471, DOI 10.2165/00002512-200522060-00002
· Hickey P, 2012, CURR NEUROL NEUROSCI, V12, P376, DOI 10.1007/s11910-012-0279-2
· Hiltunen M, 2006, Minerva Endocrinol, V31, P61
· Horti AG, 2006, J NUCL MED, V47, P1689
· Hu S, 2012, MOL IMAGING BIOL, V14, P762, DOI 10.1007/s11307-012-0551-5
· Ishiwata K, 2000, ANN NUCL MED, V14, P81, DOI 10.1007/BF02988585
· Jager R, 2012, BIOCH RES INT
· Kachroo A, 2005, J NEUROSCI, V25, P10414, DOI 10.1523/JNEUROSCI.3660-05.2005
· Kannan P, 2011, ACS CHEM NEUROSCI, V2, P82, DOI 10.1021/cn100078a
· Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869
· Keane PC, 2011, PARKINSONS DIS, V2011, P716871
· Knudsen Gerber DS, 2011, CONSULT PHARM, V26, P48
· Kong FL, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/671708
· Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369
· Kugaya A, 2000, ANN NUCL MED, V14, P1, DOI 10.1007/BF02990472
· Kuppers E, 2008, EUR J NEUROSCI, V28, P2173, DOI 10.1111/j.1460-9568.2008.06531.x
· Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006
· Li GL, 2012, BRIT J CLIN PHARMACO, V73, P706, DOI 10.1111/j.1365-2125.2011.04137.x
· Lim JH, 2008, PHARMACOL RES, V57, P325, DOI 10.1016/j.phrs.2008.03.004
· Lin PY, 2012, J CLIN PSYCHIAT, V73, P1245, DOI 10.4088/JCP.11r07546
· Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
· Liu H, 2012, ARQ NEURO-PSIQUIAT, V70, P214, DOI 10.1590/S0004-282X2012000300012
· Liu ZL, 2011, NUCL MED BIOL, V38, P795, DOI 10.1016/j.nucmedbio.2011.02.012
· Lou ZY, 2011, MOL IMMUNOL, V49, P453, DOI 10.1016/j.molimm.2011.09.016
· Lubberink M, 2007, J CEREBR BLOOD F MET, V27, P424, DOI 10.1038/sj.jcbfm.9600349
· Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400
· Luchtman DW, 2012, BEHAV BRAIN RES, V226, P386, DOI 10.1016/j.bbr.2011.09.033
· Luurtsema G, 2009, NUCL MED BIOL, V36, P643, DOI 10.1016/j.nucmedbio.2009.03.004
· Luurtsema G, 2005, NUCL MED BIOL, V32, P87, DOI 10.1016/j.nucmedbio.2004.06.007
· Luurtsema G, 2003, NUCL MED BIOL, V30, P747, DOI 10.1016/S0969-8051(03)00078-7
· Machado A., 2011, PARKINSONS DIS, V2011
· Maia S, 2012, SYNAPSE, V66, P573, DOI 10.1002/syn.21543
· Mairinger S, 2012, NUCL MED BIOL, V39, P1219, DOI 10.1016/j.nucmedbio.2012.08.005
· Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010
· Martic-Kehl MI, 2012, EUR J NUCL MED MOL I, V39, P1492, DOI 10.1007/s00259-012-2175-z
· MATTAMMAL MB, 1995, J NEUROCHEM, V64, P1645
· Mattner F, 2011, EUR J NUCL MED MOL I, V38, P1516, DOI 10.1007/s00259-011-1784-2
· Meng QJ, 2010, EUR J PHARMACOL, V649, P127, DOI 10.1016/j.ejphar.2010.09.046
· Mishina M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017338
· MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8
· MOGI M, 1994, NEUROSCI LETT, V165, P208, DOI 10.1016/0304-3940(94)90746-3
· MOGI M, 1995, NEUROSCI LETT, V193, P129, DOI 10.1016/0304-3940(95)11686-Q
· Mollereau B, 2013, CELL DEATH DIFFER, V20, P181, DOI 10.1038/cdd.2012.82
· Montgomery SL, 2012, J NEUROIMMUNE PHARM, V7, P42, DOI 10.1007/s11481-011-9287-2
· Morale MC, 2008, BRAIN RES REV, V57, P431, DOI 10.1016/j.brainresrev.2007.10.011
· Morissette M, 2008, MOL CELL ENDOCRINOL, V290, P60, DOI 10.1016/j.mce.2008.04.008
· Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544
· Munnink THO, 2011, J NUCL MED, V52, P2001, DOI 10.2967/jnumed.111.092809
· Nakaso K, 2008, NEUROSCI LETT, V432, P146, DOI 10.1016/j.neulet.2007.12.034
· Nguyen QD, 2012, EUR J CANCER, V48, P432, DOI 10.1016/j.ejca.2011.11.033
· Nicchia GP, 2003, FASEB J, V17, P1508, DOI 10.1096/fj.02-1183fje
· Noguchi J, 1998, J NUCL MED, V39, P498
· Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8
· ONDA K, 1994, ACTA NEUROPATHOL, V87, P586
· Ongini E, 1996, TRENDS PHARMACOL SCI, V17, P364, DOI 10.1016/S0165-6147(96)10045-6
· Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338
· Ouellet M, 2009, NEUROCHEM INT, V55, P476, DOI 10.1016/j.neuint.2009.04.018
· Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468
· Park Nguyen H, 2012, JAAPA, V25, P73
· Paul S, 2011, J NUCL MED, V52, P1293, DOI 10.2967/jnumed.111.088005
· Pavese N, 2012, NEUROIMAGE, V59, P1080, DOI 10.1016/j.neuroimage.2011.09.034
· Pifferi F, 2011, NUTR NEUROSCI, V14, P51, DOI 10.1179/1476830510Y.0000000001
· Pimlott SL, 2011, CHEM SOC REV, V40, P149, DOI 10.1039/b922628c
· Pinna A, 2005, EUR J PHARMACOL, V512, P157, DOI 10.1016/j.ejphar.2005.01.057
· Plaat B, 1999, EUR J NUCL MED, V26, P328, DOI 10.1007/s002590050394
· Puren AJ, 1998, J CLIN INVEST, V101, P711, DOI 10.1172/JCI1379
· Quesada A, 2008, DEV NEUROBIOL, V68, P632, DOI 10.1002/dneu.20609
· Quilty MC, 2006, EXP NEUROL, V199, P249, DOI 10.1016/j.expneurol.2005.10.018
· Rahmim A, 2008, NUCL MED COMMUN, V29, P193, DOI 10.1097/MNM.0b013e3282f3a515
· Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1053/JNEUROSCI.4540-04.2005
· Ramlackhansingh AF, 2011, NEUROLOGY, V76, P1811, DOI 10.1212/WNL.0b013e31821ccce4
· Rapoport SI, 2011, PROSTAG OTH LIPID M, V96, P109, DOI 10.1016/j.prostaglandins.2011.06.003
· Rapoport SI, 2003, J PEDIATR, V143, pS26, DOI 10.1067/S0022-3476(03)00399-8
· Rapoport SI, 2008, J NUTR, V138, P2515
· Rapoport SI, 2001, J LIPID RES, V42, P678
· Rentzos M, 2009, ACTA NEUROL SCAND, V119, P332, DOI 10.1111/j.1600-0404.2008.01103.x
· Reshef A, 2010, J NUCL MED, V51, P837, DOI 10.2967/jnumed.109.063917
· ROBINSON PJ, 1992, BRAIN RES REV, V17, P187, DOI 10.1016/0165-0173(92)90016-F
· Roselli CF, J STEROID BIOCH MOL, V106, P143
· Roussa E, 2009, ADV EXP MED BIOL, V651, P81
· Ryoo HD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008797
· Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016
· Scarselli M, 2001, ADV NEUROL, V86, P367
· Schinkel AH, 1999, ADV DRUG DELIVER REV, V36, P179, DOI 10.1016/S0169-409X(98)00085-4
· Schoder H, 2004, SEMIN NUCL MED, V34, P274, DOI 10.1053/j.semnuclmed.2004.06.004
· Scotter EL, 2010, BRIT J PHARMACOL, V160, P480, DOI 10.1111/j.1476-5381.2010.00735.x
· Seibyl JP, 2008, SEMIN NUCL MED, V38, P274, DOI 10.1053/j.semnuclmed.2008.03.001
· Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450
· Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7
· Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200
· Shim JH, 2011, MITOCHONDRION, V11, P707, DOI 10.1016/j.mito.2011.05.013
· Sidhu A, 2004, ANN NY ACAD SCI, V1035, P250, DOI 10.1196/annals.1332.016
· Singer Carlos, 2012, Cleve Clin J Med, V79 Suppl 2, pS3, DOI 10.3949/ccjm.79.s2a.01
· Skaddan MB, 2012, NUCL MED BIOL, V39, P1058, DOI 10.1016/j.nucmedbio.2012.03.011
· Stoessl AJ, 2007, PARKINSONISM RELAT D, V13, pS421, DOI 10.1016/S1353-8020(08)70041-5
· Stoll G, 2000, J NEURAL TRANSM-SUPP, P81
· Svenningsson P, 1999, PROG NEUROBIOL, V59, P355, DOI 10.1016/S0301-0082(99)00011-8
· Tait JF, 2008, J NUCL MED, V49, P1573, DOI 10.2967/jnumed.108.052803
· Takahashi K, 2011, BIOORGAN MED CHEM, V19, P1464, DOI 10.1016/j.bmc.2010.12.057
· Tang CC, 2010, J NEUROSCI, V30, P1049, DOI 10.1523/JNEUROSCI.4188-09.2010
· Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004
· Tapia-Gonzalez S, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-72
· Terry G, 2008, NEUROIMAGE, V41, P690, DOI 10.1016/j.neuroimage.2008.03.004
· Terry GE, 2010, J NUCL MED, V51, P112, DOI 10.2967/jnumed.109.067074
· Terry GE, 2009, NEUROIMAGE, V48, P362, DOI 10.1016/j.neuroimage.2009.06.059
· Thambisetty M, 2012, J CEREBR BLOOD F MET, V32, P676, DOI 10.1038/jcbfm.2011.171
· Toornvliet R, 2006, CLIN PHARMACOL THER, V79, P540, DOI 10.1016/j.clpt.2006.02.004
· Turkman N, 2012, NUCL MED BIOL, V39, P593, DOI 10.1016/j.nucmedbio.2011.10.019
· Turkman N, 2011, BIOORGAN MED CHEM, V19, P5698, DOI 10.1016/j.bmc.2011.07.062
· Van Laere K, 2012, NEUROBIOL AGING, V33
· VanBrocklin HF, 2007, NUCL MED BIOL, V34, P109, DOI 10.1016/j.nucmedbio.2006.10.005
· van Dyck CH, 2000, NEUROBIOL AGING, V21, P497, DOI 10.1016/S0197-4580(00)00152-4
· van Waarde A, 2009, J MED CHEM, V52, P4524, DOI 10.1021/jm900485a
· Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
· Visser FC, 2001, CORONARY ARTERY DIS, V12, pS12
· Vortherms TA, 2004, J PHARMACOL EXP THER, V308, P221, DOI 10.1124/jpet.103.057083
· Wanek T, 2012, J CEREBR BLOOD F MET, V32, P2002, DOI 10.1038/jcbfm.2012.112
· Wang M, 2012, BIOORG MED CHEM LETT, V22, P1569, DOI 10.1016/j.bmcl.2011.12.136
· Willmann JK, 2008, NAT REV DRUG DISCOV, V7, P591, DOI 10.1038/nrd2290
· Wilson AA, 2011, NUCL MED BIOL, V38, P247, DOI 10.1016/j.nucmedbio.2010.08.001
· Wyffels L, 2010, NUCL MED BIOL, V37, P665, DOI 10.1016/j.nucmedbio.2010.03.009
· Wyffels L, 2009, J MED CHEM, V52, P4613, DOI 10.1021/jm900324e
· Xiong HQ, 2009, J NEUROSCI, V29, P5463, DOI 10.1523/JNEUROSCI.5103-08.2009
· Y uzuki, 2012, J NEUROIMAGING, V23, P219
· Yamada M, 2010, BIOCHEM BIOPH RES CO, V402, P312, DOI 10.1016/j.bbrc.2010.10.023
· Yasuno F, 2008, NEUROPSYCHOPHARMACOL, V33, P259, DOI 10.1038/sj.npp.1301402
· Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696
· Yu M, 2009, EUR J NUCL MED MOL I, V36, P63, DOI 10.1007/s00259-008-0909-8
· Zhang CD, 2010, J NUTR, V140, P858, DOI 10.3945/jn.109.114884
· Zhang L, 2012, NEURAL REGEN RES, V7, P141, DOI 10.3969/j.issn.1673-5374.2012.02.011
· Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com
· Zubal G, 2009, SOC NUCL MED ANN M, V50, P1221
dc.description.index MEDLINE
hcfmusp.citation.scopus 3
hcfmusp.citation.wos 3
hcfmusp.affiliation.country Brasil
hcfmusp.affiliation.country Holanda


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics